JAK Inhibition as a New Treatment Strategy for Patients with COVID-19

After the advent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the outbreak of coronavirus disease 2019 (COVID-19) commenced across the world. Understanding the Immunopathogenesis of COVID-19 is essential for interrupting viral infectivity and preventing aberrant immune responses...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int Arch Allergy Immunol
Autores principales: Seif, Farhad, Aazami, Hossein, Khoshmirsafa, Majid, Kamali, Monireh, Mohsenzadegan, Monireh, Pornour, Majid, Mansouri, Davood
Formato: Artigo
Lenguaje:Inglês
Publicado: S. Karger AG 2020
Materias:
Clinical Immunology - Review Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7270061/
https://ncbi.nlm.nih.gov/pubmed/32392562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000508247
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares